| abstract |
The present invention provides a peptide having an ATF3 binding ability represented by any one amino acid sequence selected from the group consisting of SEQ ID NOs: 1 to 4 and a fusion peptide to which a peptide having cell permeability is bound, and inflammatory diseases, metabolic diseases, A therapeutic use of autoimmune diseases and / or fibrotic diseases. In the present invention, the intracellular concentration of ATF3 is regulated by providing a novel peptide having ATF3 binding ability, a protein that acts as a biomarker and a factor important for the development of various inflammatory, metabolic, autoimmune and / or fibrotic diseases. Thus, it can be used for the treatment of inflammatory diseases, metabolic diseases, autoimmune diseases and / or fibrotic diseases, and further fusion of the peptides having intracellular permeability and inflammation inhibitory function to the peptides can enhance the disease treatment effect. have. |